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Introduction
Osteoarthritis (OA) is an inflammatory 
degenerative articular disease of the joints common 
in elderly patients older than 50 years. This disorder is 
characterized by damage narrowing the joint gap, pain, 
and loss of joint function [1]. OA is one of the disorders with 
the highest morbidity in elderly patients, which will cause 
disability and require substantial funds in management and 
rehabilitation. As the degree of health and advancement 
in the medical world increases, it causes an increase in 
life expectancy which leads to an increase in elderly 
population. Radiography is an important investigation 
used to diagnose OA, although this examination is unable 
to detect and monitor biochemical and molecular changes 
that occur in joint tissues long before the onset of symptoms 
from OA or the appearance of disabilities due to OA [2].
In the management of OA, the modulation 
the specific mechanisms of the immune systems 
plays a role, such as tumor necrosis factor-α (TNF-α), 
Interleukin 1 (IL-1), and IL-6 signaling, or lymphocyte 
activation [2].
Joint effusion is a clinical feature often found 
in OA patients. Apart from joint pain and radiologic 
osteophytes, nine out of ten people with OA exhibit 
a clinical picture of joint effusion. Joint effusion is a 
condition that precedes damage to the joints which 
will lead to osteophyte formation and narrowing of 
the joints resulting in pain and movement disorders 
in OA patients. Joint effusion is an initial pathological 
condition of OA that needs to be explored to obtain 
novel biological markers that are expected to be 
developed into predictors in the diagnosis, prognosis, 
and management of OA [3], [4].
Joint effusion is believed to be closely related 
to joint inflammation. Inflammation is a pathological 
condition that forms the basis of joint effusion. 
Inflammatory conditions of the joints will cause pro-
inflammatory cytokine activation, TNF–alpha, and 
IL-1B. TNF-alpha and IL-1B will initiate the activation 
of reactive oxygen species, an oxidant, which will lead 
to the activation of proteolytic enzymes in the joints. 
Proteolytic enzymes will yield in matrix degradation 
of the cartilage and lead to joint cartilage damage 
and hence impaired joint mobility. The severity of joint 
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effusion was hypothesized to be directly proportional 
to the levels of pro-inflammatory cytokine, TNF-alpha, 
and IL-1B. The more severe the joint effusion, the pro-
inflammatory cytokine levels will increase [2], [5], [6].
Central dogma states that every expression 
of a protein is preceded by a process of transcription 
and translation, as well as in the expression of 
TNF-alpha and IL-1B proteins in joint inflammation. 
TNF-alpha and IL-1B protein expression is 
regulated by various other regulatory proteins such 
as transcription factor proteins that play a role in 
initiating the expression of a particular protein gene. 
Transcription factor proteins are hypothesized to 
regulate the expression of pro-inflammatory proteins. 
Nuclear factor of activated T-cells 1 (NFATC1) and 
chromosome 1 open reading frame 38 (C1orf38) are 
transcription factors that play a role in the expression 
of pro-inflammatory cytokine protein. NFATC1 will 
mediate the activation of TNF-alpha and IL-1B 
transcription genes, which will cause expression of 
pro-inflammatory proteins [7]. C1orf38 is an open 
reading frame factor group, which plays a role in the 
initiation of transcription of pro-inflammatory cytokine 
genes, TNF-alpha, and IL-1B [8], [9]. The presence of 
NFATC1 transcription factors must be accompanied 
by the presence of C1orf38 transcription factors in 
initiating transcription of the pro-inflammatory cytokine 
gene. Therefore, these two transcription factors are 
very important regulatory proteins in the expression 
of pro-inflammatory cytokine protein [10], [11], [12].
This study aimed to explore the role of the 
expression of pro-inflammatory cytokine (TNF-alpha 
and IL-1B) and transcription regulatory proteins 
(NFATC1 and C1orf38) with the severity of joint effusion 
in OA patients.
Methods
Study design
This study was an observational study with a 
case series study approach. In this study, observations 
of the expression of pro-inflammatory cytokine 
(TNF-alpha and IL-1B) and transcriptional regulatory 
proteins (NFATC1 and C1orf38) were then correlated 
with clinical, laboratory, and severity joint effusion 
features in OA patients.
Study subjects
A total of 80 study subjects who met the 
inclusion criteria (age >40 years; OA was diagnosed; 
joint effusion feature was present; and agreed to 
participate in the study by signing informed consent) 
were included in this study. The OA subjects were the 
patients that visited Dr. Moh Hoesin General Hospital 
and Su’adah Clinic, Palembang, Indonesia, within the 
period of January–June 2019. This study was approved 
by the Ethics Committee of the Faculty of Medicine, 
Universitas Sriwijaya/Dr. Moh Hoesin General Hospital 
(No.021/kptfkunsri-rsmh/2019).
Physical and blood examination
Subjects basic data were obtained with age 
and body mass index (BMI) being emphasized. BMI 
mean in this study was assessed with the category 
suggested for Asians: <18.5 kg/m2 (underweight); 
18.5–23 kg/m2 (normal); 23–27.5 kg/m2 (overweight); 
and 27.5 kg/m2 or higher (obesity) [13]. Random blood 
examination was performed to obtain erythrocyte 
sedimentation rate (ESR) and qualitative C-reactive 
protein (CRP) to evaluate the level of inflammation in 
the body. ESR mean value was assessed with normal 
value below 20 mm/h [14]. CRP was presented in 
negative or positive results.
OA examination
The diagnosis of OA was based on clinical 
and radiologic assessment from American College of 
Rheumatology, namely, knee pain with osteophytes plus 
one of three criteria: Age over 40 years, joint stiffness 
in the morning <30 min, and/or crepitus. In radiologic 
examination, the Kellgren-Lawrence criteria were 
used. Score 0: Normal: (1) narrowing of the joint gap 
is doubtful and can be accompanied by osteophytes; 
(2) osteophytes are clear and can be accompanied 
by narrowing of the joint gap; (3) multiple moderate 
osteophytes with clear narrowing of joint gaps, 
sometimes with sclerosis and may also be accompanied 
by bone contour deformity; and (4) osteophytes are 
large and are characterized by narrowing of the joint 
gap, severe sclerosis and clear deformity of the bone 
contour. OA was radiologically enforced when the 
Kellgren-Lawrence score ≥2 [15]. Tegner Lysholm knee 
scoring scale was used to assess how OA condition 
affected the patients’ ability to manage in daily living, 
with score >90 as excellent, 84–90 good, 65–83 fair, 
and <65 poor [16].
Joint effusion examination
Joint effusion clinical enforcement was based 
on a physical examination of the balloon sign and a 
positive stroke sign. Balloon sign examination was 
performed on the patient in a supine position and 
knee extension, where one of the examiner hands 
was on the suprapatellar part and the other hand 
held the lateral and medial side of the patella. The 
examiner’s hand on the suprapatellar part pushed 
the fluid and the other examiner’s hand sensed the 
fluid push. A stroke test was performed at the supine 
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position with knee extension and maximum relaxation. 
Examination started from the medial tibiofemoral 
joint line, examiners pushed up 2–3 times toward the 
suprapatellar gap in an attempt to move the swelling 
in the joint capsule to the suprapatellar gap. The 
examiner then pushed down on the lateral distal thigh, 
just above the suprapatellar gap, toward the lateral 
joint line. Fluid waves could be observed in seconds 
on the medial side of the knee.
The degree of joint effusion was assessed in 
semi-quantitative and quantitative. Semi-quantitative 
assessment was done based on a stroke test and 
quantitative assessment was based on the volume of 
joint aspiration obtained in milliliters (ml). A stroke test 
was assessed as “trace” if a small wave appeared on 
the medial side with push down; +1 if there was a 
large protrusion on the medial side with downward 
push; +2 if effusion spontaneously returned to the 
medial side after upward pushing (no downward 
pushing needed); and +3 excessive fluid, was not 
possible to move the effusion outside the medial 
aspect of the knee.
Pro-inflammatory cytokine and regulator 
protein assay
TNF-alpha, IL-1B, NFATC1, and C1orf38 
levels were assessed in joint fluid using the enzyme-
linked immunosorbent assay (ELISA) method (Cloud-
Clone®). Obtained joint fluid was put into a 1.5 mL 
centrifuge tube (Eppendorf®), and then a centrifuge 
(Bio-Rad®) was carried out at a speed of 5000 rpm, 
at 25°C, for 20 min. Centrifugation supernatant was 
separated from the pellet, then stored at −20°C. 
A total of 10 μL supernatants from each sample 
was put into each ELISA well microplate, and then 
incubated for 30 min, at 37°C. After washing with 
washing liquid with immune washer (Bio-Rad®), 
horseradish peroxidase-link was administered, 
followed by incubation and washing, then adding 
of chrome A and B to each well. After incubation, 
a stop solution was added and a microplate was 
immediately inserted into the ELISA reader (Bio-
Rad®) to measure optical density (OD) of each well 
at a wavelength of 450 nm. Subsequent analysis, 
the conversion of OD values to levels (pg/mL), was 
performed using a standard curve equation.
Statistical analysis
Data processing of the results of the study 
was carried out using SPSS 24, with a significance 
of p < 0.05. Data were presented as mean ± SD 
(standard deviation). Univariate analysis was presented 
in the form of frequency tabulations. Bivariate analysis 
that presented correlations between variables was 
performed by correlation analysis using the Pearson 
correlation test.
Results
Baseline characteristics of study subjects
As shown in Table 1, BMI mean value was at 
the category of overweight. A total of 80 subjects of 
Table 1: Baseline characteristics of OA subjects with effusion
S. No Baseline characteristics OA subjects with effusion (n=80)
1. Age (years), mean±SD 59.4±13.4
2. BMI (kg/m2), mean±SD 24.9±6.2
3. Effusion volume (ml), mean±SD 14.9±5.3
4. ESR (mm/hour), mean±SD 10.2±2.1
5. Kellgren-Lawrence score, percentage
Grade 3 45
Grade 4 55
6. Stroke test score, percentage
Score 1 25
Score 2 62.5
Score 3 12.5
7. Qualitative CRP, percentage
Positive 0
Negative 100
8. Tegner-Lysholm score, mean±SD 62.5±11.3
9. TNF-alpha (pg/ml), mean±SD 74.6±13.5
10. IL-1B (pg/ml), mean±SD 78.6±14.8
11. C1orf38 (pg/ml), mean±SD 65.2±11.5
12. NFATC1 (pg/ml), mean±SD 67.8±12.8
OA: Osteoarthritis, SD: Standard deviation, BMI: Body mass index, ESR: Erythrocyte sedimentation rate, 
CRP: C-reactive protein, TNF: Tumor necrosis factor, IL-1B: Interleukin 1B, C1orf38: Chromosome 1 open 
reading frame 38, NFATC1: Nuclear factor of activated T Cells 1.
OA patients with effusion obtained Kellgren-Lawrence 
score of Grade 3–4, stroke test score 2–3, and Tegner 
Lysholm mean score of 62.5 (poor condition), where 
these parameters indicated that the patients were in 
severe clinical conditions. It was quite surprising to 
observe the qualitative CRP and ESR values did not 
support that the state of OA with effusion was caused 
by chronic inflammation. The ESR result in this study 
was normal and CRP was 100% negative in all study 
subjects.
Correlation between effusion volume and 
inflammation
This study exhibited interesting and quite 
surprising results, as displayed in Table 2 and Figure 1. 
Table 2: Correlation between effusion volume and 
inflammation
Inflammatory markers r p
ESR 0.078 0.169
TNF-alpha −0.087 0.112
IL-1B −0.078 0.136
C1orf38 −0.088 0.121
NFATC1 −0.081 0.102
ESR: Erythrocyte sedimentation rate, TNF: Tumor necrosis factor, IL-1B: Interleukin 1B,  
C1orf38: Chromosome 1 open reading frame 38, NFATC1: Nuclear factor of activated T cells 1.
Inflammation has been believed to play a major role in 
the severity of effusion in patients with OA. Otherwise 
in this study, ESR did not correlate with the severity of 
OA joint effusion (p adjusted = 0.169; r = 0.078). Pro-
inflammatory cytokine level of TNF-alpha did not correlate 
with the severity of OA joint effusion (p adjusted = 0.112; 
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r = −0.087). The result of correlation between IL-1B level 
to the severity of OA joint effusion was in line with the 
previous results of TNF-alpha and ESR, where there 
was no correlation between IL-1B level with severity of 
OA joint effusion (p adjusted = 0.136, r = −0.078). OA 
joint effusion severity was not in line with an increase 
in C1orf38 level (p adjusted = 0.121; r = −0.088) and 
NFATC1 level (p adjusted = 0.102; r = −0.081).
Discussion
This study was an exploratory study conducted in 
the context of exploring the role of the inflammatory pathway 
on joint effusion severity in OA cases. Inflammation is a 
pathogenesis that is widely believed to play a role related 
to severity joint effusion in OA [7], [17], [18], [19], [20]. 
However, this study revealed other results related to 
joint effusion in OA. Inflammation did not play a role as 
the pathogenesis that underlay the severity of effusion. 
This study stated that there was no correlation between 
inflammatory markers with effusion volume in OA patients. 
Transcription factor proteins, NFATC1 and C1orf38 did 
not correlate with severity of joint effusion in OA. Efforts 
of upstream to downstream exploration in the pathway 
of this inflammation, yielded similar results, that the 
inflammatory pathway did not correlate with the severity 
of joints effusion in OA patients. Synovial fluid is a result 
of filtration from blood plasma, which plays a role in 
lubricating and maintaining the ability of the joints to be 
able to carry out physiological movements. Synovial fluid 
is rich in protein, especially hyaluronic acid, which is a 
protein that plays a role in the regulation of water retention 
in synovial fluid [3], [21], [22].
Micro trauma that occurs in OA underlies the 
occurrence of chronic inflammation, which results in 
Figure 1: Correlation of effusion volume to LED (a), tumor necrosis factor-alpha (b), interleukin 1B (c), chromosome 1 open reading frame 38 
(d), and nuclear factor of activated T cells 1 (e)
a
e
c d
b
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damage to the joint cartilage. This causes a decrease 
in hyaluronic acid in synovial fluid. Researchers 
hypothesized that the concentration of hyaluronic acid 
in synovial fluid might play a major role in the process 
of joint effusion in OA. The decrease of hyaluronic acid 
concentration in synovial fluid will cause transudation 
of water to the synovial which results in joint effusion. 
Hyaluronic acid exploration is suggested for further 
study to uncover the factors that play a role in the severity 
of joint effusion in OA. In addition, the exploration of 
synovial joint protein, plasma protein, is also suggested. 
A decrease in plasma protein is believed to reduce the 
concentration of protein in the synovial joint, decreasing 
the synovial fluid oncotic pressure, hence leading to 
massive transudation of water from extra synovial 
into the joint. This is believed to be one of the alleged 
factors that influence the severity of joint effusion in 
OA [23], [24], [25]. The limitation of this study was the 
absence of a control group. Further studies could be 
conducted to explore this topic.
Conclusion
Pro-inflammatory cytokines of TNF-alpha and 
IL-1B, and the transcription factors of pro-inflammatory 
cytokines gene expression, NFATC1 and C1ORF38, 
did not correlate with the severity of joint effusion in OA.
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